These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 25492486

  • 21. [An experimental study on arsenic trioxide-selectively induced human hepatocarcinoma cell lines apoptosis and its related genes].
    Liu L, Qin S, Chen H, Wang J, Chen H, Ma J, Liu W.
    Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):367-9. PubMed ID: 11135700
    [Abstract] [Full Text] [Related]

  • 22. Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma.
    Zhang X, Yang XR, Sun C, Hu B, Sun YF, Huang XW, Wang Z, He YF, Zeng HY, Qiu SJ, Cao Y, Fan J, Zhou J.
    Cancer Lett; 2015 Sep 28; 366(1):112-22. PubMed ID: 26118777
    [Abstract] [Full Text] [Related]

  • 23. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.
    Canestraro M, Galimberti S, Savli H, Palumbo GA, Tibullo D, Nagy B, Guerrini F, Piaggi S, Cine N, Metelli MR, Petrini M.
    Cancer Genet Cytogenet; 2010 Jun 28; 199(2):110-20. PubMed ID: 20471514
    [Abstract] [Full Text] [Related]

  • 24. Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway.
    Ling S, Song L, Fan N, Feng T, Liu L, Yang X, Wang M, Li Y, Tian Y, Zhao F, Liu Y, Huang Q, Hou Z, Xu F, Shi L, Li Y.
    Int J Oncol; 2017 Jan 28; 50(1):297-309. PubMed ID: 27959383
    [Abstract] [Full Text] [Related]

  • 25. Novel phyto-derivative BRM270 inhibits hepatocellular carcinoma cells proliferation by inducing G2/M phase cell cycle arrest and apoptosis in xenograft mice model.
    Kumar Mongre R, Sharma N, Singh Sodhi S, Ghosh M, Kumar Singh A, Kim N, Park YH, Shin YG, Kim SJ, Jiao Jiao Z, Huynh DL, Jeong DK.
    Biomed Pharmacother; 2017 Mar 28; 87():741-754. PubMed ID: 28110264
    [Abstract] [Full Text] [Related]

  • 26. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
    Chen G, Wang K, Yang BY, Tang B, Chen JX, Hua ZC.
    Int J Oncol; 2012 Jan 28; 40(1):139-47. PubMed ID: 21947421
    [Abstract] [Full Text] [Related]

  • 27. Metformin incombination with curcumin inhibits the growth, metastasis, and angiogenesis of hepatocellular carcinoma in vitro and in vivo.
    Zhang HH, Zhang Y, Cheng YN, Gong FL, Cao ZQ, Yu LG, Guo XL.
    Mol Carcinog; 2018 Jan 28; 57(1):44-56. PubMed ID: 28833603
    [Abstract] [Full Text] [Related]

  • 28. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
    Schulze-Bergkamen H, Fleischer B, Schuchmann M, Weber A, Weinmann A, Krammer PH, Galle PR.
    BMC Cancer; 2006 Oct 02; 6():232. PubMed ID: 17014711
    [Abstract] [Full Text] [Related]

  • 29. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
    You A, Cao M, Guo Z, Zuo B, Gao J, Zhou H, Li H, Cui Y, Fang F, Zhang W, Song T, Li Q, Zhu X, Yin H, Sun H, Zhang T.
    J Hematol Oncol; 2016 Mar 08; 9():20. PubMed ID: 26957312
    [Abstract] [Full Text] [Related]

  • 30. BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma.
    Galmiche A, Ezzoukhry Z, François C, Louandre C, Sabbagh C, Nguyen-Khac E, Descamps V, Trouillet N, Godin C, Regimbeau JM, Joly JP, Barbare JC, Duverlie G, Mazière JC, Chatelain D.
    Mol Cancer Res; 2010 Aug 08; 8(8):1116-25. PubMed ID: 20647330
    [Abstract] [Full Text] [Related]

  • 31. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY, Lam SK, Li YY, Fong BM, Mak JC, Ho JC.
    Lung Cancer; 2013 Nov 08; 82(2):222-30. PubMed ID: 24041618
    [Abstract] [Full Text] [Related]

  • 32. Delivery of Arsenic Trioxide by Multifunction Nanoparticles To Improve the Treatment of Hepatocellular Carcinoma.
    Wu Q, Chen X, Wang P, Wu Q, Qi X, Han X, Chen L, Meng X, Xu K.
    ACS Appl Mater Interfaces; 2020 Feb 19; 12(7):8016-8029. PubMed ID: 31997633
    [Abstract] [Full Text] [Related]

  • 33. Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.
    Gandhy SU, Imanirad P, Jin UH, Nair V, Hedrick E, Cheng Y, Corton JC, Kim K, Safe S.
    Oncotarget; 2015 Sep 22; 6(28):26359-72. PubMed ID: 26317792
    [Abstract] [Full Text] [Related]

  • 34. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
    Liu ZM, Tseng HY, Cheng YL, Yeh BW, Wu WJ, Huang HS.
    Toxicol Appl Pharmacol; 2015 May 15; 285(1):41-50. PubMed ID: 25791921
    [Abstract] [Full Text] [Related]

  • 35. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J, Chen X, Lin W, Wu G, Zhuang Q, Zhong X, Hong Z, Peng J.
    Int J Oncol; 2013 Mar 15; 42(3):971-8. PubMed ID: 23338043
    [Abstract] [Full Text] [Related]

  • 36. Combinatorial Effect of Arsenic and Herbal Compounds in Telomerase-Mediated Apoptosis Induction in Liver Cancer.
    Chaudhary A, Bhardwaj SK, Khan A, Srivastava A, Sinha KK, Ali M, Haque R.
    Biol Trace Elem Res; 2023 Jul 15; 201(7):3300-3310. PubMed ID: 36192614
    [Abstract] [Full Text] [Related]

  • 37. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y.
    Biochem Biophys Res Commun; 2002 Mar 08; 291(4):861-7. PubMed ID: 11866444
    [Abstract] [Full Text] [Related]

  • 38. Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo.
    Zhang T, Wang SS, Hong L, Wang XL, Qi QH.
    J Exp Clin Cancer Res; 2003 Mar 08; 22(1):61-8. PubMed ID: 12725324
    [Abstract] [Full Text] [Related]

  • 39. Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia.
    Liu Y, Gao F, Song W.
    Biomed Pharmacother; 2017 Apr 08; 88():342-348. PubMed ID: 28119236
    [Abstract] [Full Text] [Related]

  • 40. Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase.
    Liao B, Liang H, Chen J, Liu Q, Zhang B, Chen X.
    Tumour Biol; 2015 Dec 08; 36(12):9347-56. PubMed ID: 26108995
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.